Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Current pharmacotherapies for major depressive disorder (MDD) have a distinct lag of onset that can prolong distress and impairment for patients, and real-world effectiveness trials further suggest that antidepressant efficacy is limited in many patients. All currently approved antidepressant medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaso, Brittany A., Niciu, Mark J., Iadarola, Nicolas D., Lally, Níall, Richards, Erica M., Park, Minkyung, Ballard, Elizabeth D., Nugent, Allison C., Machado-Vieira, Rodrigo, Zarate, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327449/
https://www.ncbi.nlm.nih.gov/pubmed/26997505
http://dx.doi.org/10.2174/1570159X14666160321123221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327449/
https://www.ncbi.nlm.nih.gov/pubmed/26997505
http://dx.doi.org/10.2174/1570159X14666160321123221

Ejemplares similares